Abstract

Pulmonary hypertension (PH) is defined as an elevated mean pulmonary artery pressure at rest (mPAP ≥ 25 mmHg), evaluated by right heart catheterization (RHC). The aim of the present study was to evaluate HRCT findings in relation to transthoracic echocardiographic data to better characterize PH in IPF patients and to identify a non-invasive composite index with high predictive value for PH in these patients. 37 IPF patients were enrolled in this retrospective study. All patients underwent a complete assessment for PH, including transthoracic Doppler echocardiography, HRCT scan and right heart catheterization. Right heart catheterization was done in 19 patients (51.3%) as pre-lung transplant assessment and in 18 patients (48.6%) to confirm PH, suspected on the basis of echocardiography. Twenty out of 37 patients (54%) were confirmed to have PH by RHC. Multivariate regression showed that the combination of sPAP, PA area measured by HRCT and the ratio of the diameter of the segmental artery to that of the adjacent bronchus in the apicoposterior segment of the left upper lobe was strongly correlated with mPAP (R2 = 0.53; p = 0.0009). The ROC analysis showed that 931.6 was the ULN for PA area, with 86% sensitivity and 61% specificity (0.839 AUC); 20.34 was the ULN for the ratio of PA area to ascending aorta diameter, with 100% sensitivity and 50% specificity (0.804 AUC). The composite index proposed in the present study could help early detection of IPF patients suspected of PH requiring confirmation by RHC (if deemed clinically necessary).

Highlights

  • Pulmonary hypertension (PH) is defined as an elevated mean pulmonary artery pressure at rest, evaluated by right heart catheterization (RHC)

  • Inclusion criteria included diagnosis of idiopathic pulmonary fibrosis (IPF) according to the latest evidence-based guidelines of the American Thoracic Society and European Respiratory Society/ALAT/JRS [4], pulmonary artery pressure measured by right heart catheterization performed for clinical purposes, chest High-resolution computed tomography (HRCT) and echocardiography within 1 month of RHC, and HRCT imaging performed at our institution

  • The following lung function measurements were collected at the time of blood sampling (Table 3) and 6 months later: forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), total lung capacity (TLC), residual volume (RV), diffusing capacity of the lung for carbon monoxide (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume

Read more

Summary

Introduction

Pulmonary hypertension (PH) is defined as an elevated mean pulmonary artery pressure at rest (mPAP ≥ 25 mmHg), evaluated by right heart catheterization (RHC). We focused on PH associated with idiopathic pulmonary fibrosis (IPF), which is the most common idiopathic interstitial pneumonia. Internal and Emergency Medicine (2021) 16:941–947 classified in group 3: PH due to lung disease and/or hypoxia [1, 3]. Idiopathic pulmonary fibrosis is a progressive and often fatal idiopathic interstitial pneumonia with a median survival of 3–5 years. It is limited to the lung and associated with a histological and/or radiological pattern of usual interstitial pneumonia [4]. The development of PH has a negative impact on quality of life of IPF patients and is associated with poor outcomes [5,6,7]. It has been demonstrated that PH affects survival by increasing the risk of death [5,6,7,8,9]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call